股份回购
Search documents
上海莱士血液制品股份有限公司关于股份回购完成暨回购实施结果的公告
Shang Hai Zheng Quan Bao· 2025-10-28 23:15
Core Viewpoint - Shanghai Laishi Blood Products Co., Ltd. has completed its share repurchase plan, acquiring a total of 69,081,952 shares, which represents 1.04% of the company's total share capital, with a total expenditure of approximately RMB 474.94 million [4][6]. Summary by Sections Share Repurchase Plan - The company approved a share repurchase plan on January 13, 2025, with a total budget between RMB 250 million and RMB 500 million, and a maximum repurchase price of RMB 9.55 per share [2][3]. - The repurchase period is set for 12 months from the approval date, with the possibility of early completion if certain conditions are met [2]. Implementation Details - The repurchase was executed from April 2, 2025, to October 28, 2025, through a centralized bidding method [4]. - The highest transaction price was RMB 7.09 per share, and the lowest was RMB 6.62 per share [4]. Compliance and Impact - The repurchase was conducted in accordance with relevant regulations, and the execution details aligned with the approved plan [5][12]. - The completion of the repurchase is not expected to significantly impact the company's financials, operations, or debt obligations, nor will it alter the company's control status [6]. Future Arrangements - The repurchased shares will be used for employee stock ownership plans or equity incentives, with no immediate changes to the total share capital [14]. - If the shares are not utilized within 12 months, they will be canceled, leading to a reduction in registered capital [15].
禾丰食品股份有限公司关于股份回购实施结果暨股份变动的公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-10-28 20:29
Group 1 - The company approved a share repurchase plan on October 28, 2024, with a total amount not exceeding RMB 200 million and not less than RMB 100 million, at a maximum price of RMB 10.90 per share, for a period of up to 12 months [2] - The company completed the share repurchase on October 27, 2025, having repurchased 17,303,064 shares, which is 1.90% of the total share capital, with a total expenditure of RMB 145.4592 million [3][4] - The execution of the repurchase plan was consistent with the original disclosure, and the company confirmed that the implementation would not significantly impact its operational and financial status [5][4] Group 2 - The repurchased shares will be used for the conversion of convertible bonds, and if not utilized within 36 months, the unutilized portion will be canceled [8] - During the repurchase period, key stakeholders, including the chairman and directors, engaged in share reduction activities, with specific plans disclosed for share sales [5][6] - The company reported no other trading activities by its directors, supervisors, and major shareholders during the repurchase period [6]
海大集团拟回购10亿元至16亿元股份
Zhong Guo Ji Jin Bao· 2025-10-28 16:20
Core Viewpoint - Haida Group announced a share repurchase plan of 1 billion to 1.6 billion CNY to enhance investor confidence and optimize corporate governance after its market value fell below 100 billion CNY [1][4]. Group 1: Share Repurchase Plan - The company plans to repurchase shares using self-raised funds, with a total amount between 1 billion and 1.6 billion CNY, at a price not exceeding 62.00 CNY per share [1][4]. - 1 billion CNY of the repurchased shares will be used for cancellation and reduction of registered capital, while any amount exceeding this will be allocated for employee stock ownership plans [1][4]. - The repurchase period is set for five months following the approval by the shareholders' meeting [4]. Group 2: Financial Metrics - As of September 30, 2025, Haida Group reported total assets of 50.816 billion CNY, current assets of 25.255 billion CNY, and net assets attributable to shareholders of 25.269 billion CNY [4]. - The maximum repurchase amount of 1.6 billion CNY would represent approximately 3.15% of total assets, 6.34% of current assets, and 6.33% of net assets [4]. - The estimated number of shares to be repurchased ranges from approximately 16.13 million shares (0.97% of total shares) at the lower limit to about 25.81 million shares (1.55% of total shares) at the upper limit [4]. Group 3: Recent Stock Performance - Haida Group's stock price has decreased by 12.50% since September 15, significantly outpacing the sector's decline of 7.25% [5]. - As of October 28, the stock closed at 56.69 CNY, down 2.56%, with a total market capitalization of 94.3 billion CNY [1][6]. Group 4: Business Performance - For the first three quarters of 2025, Haida Group achieved revenue of 96.094 billion CNY, a year-on-year increase of 13.24%, and a net profit attributable to shareholders of 4.142 billion CNY, up 14.31% [7]. - The company reported a third-quarter revenue of 37.263 billion CNY, reflecting a 14.43% year-on-year growth [7]. - The overseas market has become a significant growth driver, with revenue from international markets reaching 8.218 billion CNY in the first half of 2025, a 10.87% increase year-on-year [7][8]. Group 5: Strategic Initiatives - Haida Group plans to spin off its subsidiary Haida Holdings for a listing on the Hong Kong Stock Exchange, focusing on feed, seed, and veterinary products in overseas markets [9]. - This strategic move aligns with the national "Belt and Road" initiative and aims to enhance the company's global competitiveness and influence [9].
康宁杰瑞制药-B10月28日斥资376.84万港元回购32万股
Zhi Tong Cai Jing· 2025-10-28 14:23
Core Viewpoint - Corning Incorporated announced a share buyback of 320,000 shares at a total cost of HKD 3.7684 million, with individual share prices ranging from HKD 11.53 to HKD 11.97 [1] Group 1 - The company plans to repurchase shares on October 28, 2025 [1] - The total expenditure for the buyback is approximately HKD 3.7684 million [1] - The price range for the repurchased shares is between HKD 11.53 and HKD 11.97 per share [1]
优宁维:已实施两期股份回购计划
Sou Hu Cai Jing· 2025-10-28 13:01
Core Viewpoint - The company emphasizes its commitment to stabilizing stock prices through operational performance improvement and share repurchase initiatives, aligning with regulatory guidelines on market value management [1] Group 1: Share Repurchase Plans - The company has launched two share repurchase plans in 2024, with the first plan completed, utilizing 25,987,076 yuan to repurchase 927,600 shares [1] - The shares repurchased in the first phase are intended for employee stock ownership plans or equity incentives [1] - The second phase of the repurchase plan is currently in progress, with the first transaction completed on October 14, 2025, aimed at reducing registered capital [1] Group 2: Commitment to Investor Relations - The company is dedicated to enhancing investor communication as part of its strategy to maintain stable stock price fluctuations [1] - Future efforts will continue to focus on share repurchase and equity incentive tools to improve operational quality and performance, ultimately benefiting investors [1]
超达装备:拟2500万-5000万元回购股份用于激励计划
Xin Lang Cai Jing· 2025-10-28 12:24
Core Viewpoint - The company has announced a share repurchase plan, intending to use between 25 million to 50 million yuan of its own or raised funds to buy back A-shares at a price not exceeding 65.44 yuan per share [1] Summary by Categories Share Repurchase Plan - The board of directors has approved a share repurchase plan with a budget of 25 million to 50 million yuan [1] - The maximum price for the repurchase is set at 65.44 yuan per share [1] - If the upper limit is reached, approximately 764,058 shares will be repurchased, accounting for 0.95% of the total share capital; if the lower limit is reached, around 382,029 shares will be repurchased, accounting for 0.48% [1] Purpose and Conditions - The repurchased shares will be used for equity incentives or employee stock ownership plans [1] - If the shares are not utilized within three years, they will be canceled [1] - The implementation period for the repurchase is set at 12 months [1] Current Status - As of the announcement date, there are no clear plans for additional buying or selling by relevant parties [1] - The repurchase may face risks related to stock price fluctuations and significant events that could hinder its execution [1]
力源信息:拟回购不超3000万元股份
Xin Lang Cai Jing· 2025-10-28 10:55
Core Viewpoint - The company has approved a share repurchase plan aimed at reducing registered capital through the buyback of shares [1] Summary by Relevant Sections - **Share Repurchase Plan**: The company will repurchase shares through centralized bidding, with a total funding amount between 20 million and 30 million yuan [1] - **Funding Sources**: The funds for the buyback will come from a special loan for stock repurchase and the company's own funds [1] - **Price and Volume**: The repurchase price will not exceed 15 yuan per share, with an estimated buyback of 2 million shares at the upper limit, representing 0.17% of the total share capital, and 1.33 million shares at the lower limit, representing 0.12% of the total share capital [1] - **Repurchase Period**: The buyback will occur within six months from the date of approval by the shareholders' meeting [1]
新东方-S宣派现金股息及采纳股份回购计划
Zhi Tong Cai Jing· 2025-10-28 10:10
Group 1 - The company has announced a cash dividend and share buyback plan as part of its shareholder return program approved in July 2025 for the fiscal year 2026 [1] - The cash dividend will be $0.12 per ordinary share or $1.2 per American Depositary Share (ADS), to be paid in two installments [1] - The total cash dividend amount expected to be distributed in two installments is approximately $190 million [1] Group 2 - To qualify for the first dividend payment, ordinary shareholders must submit all valid share transfer documents by November 18, 2025 [2] - The company plans to repurchase up to $300 million of its ADS or ordinary shares within the next 12 months [2] - The repurchase may occur through various methods, including open market purchases and private negotiations, depending on market conditions and applicable laws [2]
康臣药业10月28日斥资244.97万港元回购15.9万股
Zhi Tong Cai Jing· 2025-10-28 10:04
Group 1 - The company, 康臣药业, announced a share buyback plan on October 28, 2025, involving an expenditure of HKD 2.4497 million to repurchase 159,000 shares [1] - The repurchase price per share ranged from HKD 15.26 to HKD 15.43 [1]
环旭电子上调股份回购价格上限至30元/股 较此前提升51.7%
Xin Lang Cai Jing· 2025-10-28 09:49
环旭电子股份有限公司(以下简称"环旭电子")于2025年10月29日发布公告称,公司第六届董事会第二 十一次会议已于10月27日审议通过《关于调整股份回购价格上限的议案》,决定将此前的股份回购价格 上限由不超过19.77元/股上调至不超过30.00元/股,调整幅度达51.7%。本次调整后,回购方案的资金总 额、期限等其他核心内容保持不变。 回购方案回顾 据公告披露,环旭电子于2025年4月25日首次审议通过股份回购方案,计划使用自有资金以集中竞价交 易方式回购公司股份,资金总额区间为1.5亿元至3亿元,回购期限为自董事会审议通过之日起12个月 (即2025年4月25日至2026年4月24日),初始回购价格上限为不超过20.00元/股。 后因公司实施2024年年度权益分派,自2025年6月6日(除权除息日)起,回购价格上限根据规则调整为 不超过19.77元/股。 登录新浪财经APP 搜索【信披】查看更多考评等级 本次董事会决议及相关公告已于2025年10月29日在上海证券交易所网站披露。 声明:市场有风险,投资需谨慎。 本文为AI大模型基于第三方数据库自动发布,任何在本文出现的信 息(包括但不限于个股、评论、预 ...